Louis Breton is the founder of Rampart Bioscience. Rampart Bioscience has raised $125M in total funding. Latest round: Series A. Backed by OrbiMed.
Louis Breton co-founded Rampart Bioscience in 2019, a biotechnology company based in La Jolla, California, focusing on DNA-based medicines for rare inherited conditions. Under his leadership as CEO, the company raised a total of $125 million in private financing, including an $85 million Series A round in October 2023.
Full founder directory · Investor directory · Company funding database · Fundraising library